Bringing the fundamentals into focus…
Back to IRADIMED CORPORATION
How IRADIMED CORPORATION stacks up
IRMD · against 425 other Healthcare companies of similar size
Growth
59/ 100
Above the middle of the pack.
Ranked #165 of 426 · scores higher than 60% of peers
Bars: peers in each 10-point band of the growth score38 peers with a growth score of 50–59, including IRMD · Click a bar to see the companies
Why growth scores 59?
Weighted metrics compared with all Healthcare companies.Its metrics sit close to the Healthcare norm.
- Earnings per share growth is close to the peer norm. Earnings per share growth: 11.0% vs peer median 9.8%
- faster revenue growth over the last year: stronger than 64% of peers. Revenue growth: 11.2% vs peer median 6.1%
- faster revenue growth over three years: stronger than 70% of peers. 3-year revenue growth: 13.0% vs peer median 5.8%
Metric by metric
Position: dot = IRMD, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | IRMD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 433 reported | 11.2% | 4.9% | 66% | 33% | |
| Earnings per share growthHigher is better · 236 reported | 11.0% | 5.6% | 57% | 33% | |
| 3-year revenue growthHigher is better · 419 reported | 13.0% | 5.6% | 71% | 33% |
Ranking by growth score
Top 5 and the companies ranked around IRMD| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 1 | 1.4B USD | 99 | 73 | |
| 1 | 885M USD | 99 | 33 | |
| 1 | 609M USD | 99 | 91 | |
| 5 | 595M USD | 98 | 97 | |
| 164 | 588M USD | 60 | 24 | |
| 165 | 5.1B CNY (≈$719M) | 59 | 74 | |
| 165 | 1.2B CHF (≈$1.4B) | 59 | 34 | |
| 165 | 1.2B USD | 59 | 46 | |
| 165 | 1.0B USD | 59 | 74 | |
| 165 | 1.6B USD | 59 | 30 | |
| 170 | 114.7B JPY (≈$780M) | 58 | 72 | |
| 171 | 11.3B CNY (≈$1.6B) | 57 | 76 | |
| 171 | 6.7B CNY (≈$941M) | 57 | 52 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score